These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 14664470)

  • 1. Cytapheresis with a filter for selective removal of CD4+ T cells in experimental autoimmune encephalomyelitis.
    Nakane S; Matsuo H; Goto H; Yoshinaga-Matsumoto M; Ohtsuru I; Ichinose K; Onodera H; Yoshida M; Shibuya N
    Mult Scler; 2003 Dec; 9(6):579-84. PubMed ID: 14664470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
    Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
    J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice.
    Wu L; Li N; Zhang M; Xue SL; Cassady K; Lin Q; Riggs AD; Zeng D
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15994-9. PubMed ID: 26647186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4(+) T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice.
    Van de Keere F; Tonegawa S
    J Exp Med; 1998 Nov; 188(10):1875-82. PubMed ID: 9815265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of CD20 B cells fails to inhibit relapsing mouse experimental autoimmune encephalomyelitis.
    Sefia E; Pryce G; Meier UC; Giovannoni G; Baker D
    Mult Scler Relat Disord; 2017 May; 14():46-50. PubMed ID: 28619431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell-derived nitric oxide is involved in IL-4-induced suppression of experimental allergic encephalomyelitis (EAE) in Lewis rats.
    Xu L; Huang Y; Yang J; Van Der Meide PH; Levi M; Wahren B; Link H; Xiao B
    Clin Exp Immunol; 1999 Oct; 118(1):115-21. PubMed ID: 10540168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of the memory response to encephalitogen following intergender adoptively transferred experimental autoimmune encephalomyelitis.
    Archie Bouwer HG; Gregory CR; Wegmann KW; Hinrichs DJ
    J Neuroimmunol; 2015 Jan; 278():194-9. PubMed ID: 25468271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute treatment with valproic acid and l-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats.
    Castelo-Branco G; Stridh P; Guerreiro-Cacais AO; Adzemovic MZ; Falcão AM; Marta M; Berglund R; Gillett A; Hamza KH; Lassmann H; Hermanson O; Jagodic M
    Neurobiol Dis; 2014 Nov; 71():220-33. PubMed ID: 25149263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1.
    Archelos JJ; Jung S; Mäurer M; Schmied M; Lassmann H; Tamatani T; Miyasaka M; Toyka KV; Hartung HP
    Ann Neurol; 1993 Aug; 34(2):145-54. PubMed ID: 7687838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-associated changes in rat immune system: lessons learned from experimental autoimmune encephalomyelitis.
    Djikić J; Nacka-Aleksić M; Pilipović I; Stojić-Vukanić Z; Bufan B; Kosec D; Dimitrijević M; Leposavić G
    Exp Gerontol; 2014 Oct; 58():179-97. PubMed ID: 25128713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronin 1-mediated naive T cell survival is essential for the development of autoimmune encephalomyelitis.
    Siegmund K; Zeis T; Kunz G; Rolink T; Schaeren-Wiemers N; Pieters J
    J Immunol; 2011 Mar; 186(6):3452-61. PubMed ID: 21289301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of requirement for CD8+ cells in recovery from and resistance to experimental autoimmune encephalomyelitis.
    Lohse AW; Schwerdt A; Herkel J; Spahn T; Meyer zum Büschenfelde KH
    J Autoimmun; 1995 Jun; 8(3):395-404. PubMed ID: 7576000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of experimental autoimmune encephalomyelitis by intravenously administered polyclonal immunoglobulins.
    Achiron A; Mor F; Margalit R; Cohen IR; Lider O; Miron S
    J Autoimmun; 2000 Nov; 15(3):323-30. PubMed ID: 11040073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of experimental allergic encephalomyelitis by selective removal of CD4+ T cells.
    Matsuo H; Ichinose K; Ohtsuru I; Fujishita S; Onodera H; Suematsu J; Yoshida M; Yamawaki N; Shibuya N
    Ther Apher; 1997 May; 1(2):165-8. PubMed ID: 10225764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8⁺ T cell help is required for efficient induction of EAE in Lewis rats.
    Camara M; Beyersdorf N; Fischer HJ; Herold MJ; Ip CW; van den Brandt J; Toyka KV; Taurog JD; Hünig T; Herrmann T; Reichardt HM; Weishaupt A; Kerkau T
    J Neuroimmunol; 2013 Jul; 260(1-2):17-27. PubMed ID: 23664330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
    Imler TJ; Petro TM
    Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells.
    Matarese G; Carrieri PB; La Cava A; Perna F; Sanna V; De Rosa V; Aufiero D; Fontana S; Zappacosta S
    Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5150-5. PubMed ID: 15788534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymic regulation of autoimmune disease by accelerated differentiation of Foxp3+ regulatory T cells through IL-7 signaling pathway.
    Chen X; Fang L; Song S; Guo TB; Liu A; Zhang JZ
    J Immunol; 2009 Nov; 183(10):6135-44. PubMed ID: 19841165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DAB389IL-2 suppresses autoimmune inflammation in the CNS and inhibits T cell-mediated lysis of glial target cells.
    Bhopale MK; Hilliard B; Constantinescu CS; Fujioka T; Ventura E; Phillips SM; Rostami A
    Exp Mol Pathol; 2014 Feb; 96(1):108-17. PubMed ID: 23872438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.